Kerendia 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F7UA5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,751
Award facts
- Contract value 100% obligated
- $50,751.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $50,751.39 delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) under a firm fixed-price contract. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded without set-aside designation, consistent with AmerisourceBergen's standard federal procurement approach. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The SPE2DX prime vendor contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains to military healthcare programs worldwide. DLA Troop Support is planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as one of several strategic pharmaceutical suppliers supporting federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F7UA5?
SPE2DR26F7UA5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F7UA5 worth?
The government has obligated $50,751 on SPE2DR26F7UA5.
Is contract SPE2DR26F7UA5 an order under another contract?
Yes. SPE2DR26F7UA5 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UA5 competed?
The extent of competition for SPE2DR26F7UA5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award